Detalles de la búsqueda
1.
MASLD: a systemic metabolic disorder with cardiovascular and malignant complications.
Gut
; 73(4): 691-702, 2024 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38228377
2.
The first MASH drug therapy on the horizon: Current perspectives of resmetirom.
Liver Int
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38578141
3.
Relationship between Helicobacter pylori infection and risk of metabolic dysfunction-associated steatotic liver disease: An updated meta-analysis.
Liver Int
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38567962
4.
Object detection: A novel AI technology for the diagnosis of hepatocyte ballooning.
Liver Int
; 44(2): 330-343, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38014574
5.
Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohort.
Liver Int
; 44(5): 1129-1141, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38426611
6.
Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
Arterioscler Thromb Vasc Biol
; 43(3): 482-491, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36727522
7.
Diagnostic accuracy of FibroScan-AST (FAST) score for the non-invasive identification of patients with fibrotic non-alcoholic steatohepatitis: a systematic review and meta-analysis.
Gut
; 72(7): 1399-1409, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36599683
8.
The hepato-ovarian axis: genetic evidence for a causal association between non-alcoholic fatty liver disease and polycystic ovary syndrome.
BMC Med
; 21(1): 62, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36800955
9.
Genetically predicted plasma levels of amino acids and metabolic dysfunction-associated fatty liver disease risk: a Mendelian randomization study.
BMC Med
; 21(1): 469, 2023 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38017422
10.
Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor.
Hepatology
; 76(6): 1794-1810, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35586979
11.
Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus.
Cardiovasc Diabetol
; 22(1): 204, 2023 08 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37563618
12.
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study.
Liver Int
; 43(11): 2434-2444, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37312616
13.
Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions.
Liver Int
; 43(6): 1170-1182, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37017559
14.
Novel urinary protein panels for the non-invasive diagnosis of non-alcoholic fatty liver disease and fibrosis stages.
Liver Int
; 43(6): 1234-1246, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36924436
15.
Effects of glucose-lowering agents on cardiovascular and renal outcomes in subjects with type 2 diabetes: An updated meta-analysis of randomized controlled trials with external adjudication of events.
Diabetes Obes Metab
; 25(2): 444-453, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36205446
16.
Comparison of cardiovascular mortality between MAFLD and NAFLD: A cohort study.
Nutr Metab Cardiovasc Dis
; 33(5): 947-955, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36746687
17.
Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: A panel-data analysis.
Nutr Metab Cardiovasc Dis
; 33(5): 1093-1097, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37208069
18.
Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure.
Curr Heart Fail Rep
; 20(4): 308-319, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37402108
19.
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies.
Gut
; 71(4): 778-788, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33685968
20.
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis.
Gut
; 71(1): 156-162, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33303564